FDA Warning Letter — Reliable Rexall-A Compounding Pharmacy

Case 511750 — FEI 3006164918

The FDA took a Warning Letter action against Reliable Rexall-A Compounding Pharmacy on March 10, 2017 (San Francisco, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Reliable Rexall-A Compounding Pharmacy
Date
March 10, 2017
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
San Francisco, CA (United States)